SignalXSignalX

OLMA Olema Pharmaceuticals, Inc.

8-K Current Report
Filed: March 16, 2026
Health Care
Pharmaceutical Preparations
Olema Pharmaceuticals, Inc. Overview

Olema Pharmaceuticals, Inc. (OLMA) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Full-year 2025 financial results reported March 16, 2026
  • • Full details in accompanying press release exhibit — primary source for revenue, cash, and pipeline spend figures

Get deeper insights on Olema Pharmaceuticals, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.